China Universal Asset Management »

Lyell Immunopharma shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $109k 49k 2.23
2023-12-31 $57k 29k 1.96
2023-09-30 $9.0k 6.4k 1.40
2023-06-30 $10k 3.3k 3.06
2023-03-31 $8.0k 3.4k 2.37
2022-12-31 $9.0k 2.5k 3.55
2022-09-30 $17k 2.3k 7.32

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Lyell Immunopharma

BlackRock
Vanguard Group
WuXi AppTec
T. Rowe Price Associates
Alphabet
Citadel Advisors
Sc China Holding
MIC Capital Management UK
Bank of America Corporation
Massachusetts Financial Services
Charles Schwab Investment Management
TD Asset Management
Millennium Management
Invenomic Capital Management
Baillie Gifford & Co

View all funds holding Lyell Immunopharma